Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chul Ju Han

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Colorectal Disease|June 19, 2013
Severe intestinal toxicity after stereotactic ablative radiotherapy for abdominopelvic malignanciesSun Hyun Bae, Mi-Sook Kim, So Young Kim, et al.
Experimental & Molecular Medicine|October 16, 2007
Mutation analysis of p31comet gene, a negative regulator of Mad2, in human hepatocellular carcinomaMi-Yong Yun, Sang Bum Kim, Sunhoo Park, et al.
Clinical and Molecular Hepatology|April 3, 2015
Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cellsHa Ra Gu, Su Cheol Park, Su Jin Choi, et al.
Cancers|December 11, 2022
NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP SignalingYuna Shin, Wonhee Jung, Mi-Yeon Kim, et al.
The Korean Journal of Hepatology|December 23, 2004
[Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma]Yun Ho Kong, Chul Ju Han, Sang Dae Lee, et al.
Anticancer Research|August 9, 2015
Survival Advantage Associated with Metformin Usage in Hepatocellular Carcinoma Patients Receiving Radiotherapy: A Propensity Score Matching AnalysisWon Il Jang, Mi-Sook Kim, Jung Sub Lim, et al.
Journal of Cellular Biochemistry|June 18, 2005
Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen speciesMyung-Jin Park, Jae-Young Lee, Hee-Jin Kwak, et al.
Journal of Medical Virology|April 23, 2008
High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in KoreaSu Cheol Park, Sook-Hyang Jeong, Jin Kim, et al.
Cancer|May 10, 2012
Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolizationJin-Kyu Kang, Mi-Sook Kim, Chul Koo Cho, et al.
Oncology Reports|July 18, 2018
TMEM165, a Golgi transmembrane protein, is a novel marker for hepatocellular carcinoma and its depletion impairs invasion activityJee-San Lee, Mi-Yeun Kim, Eun-Ran Park, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Colorectal Disease|June 19, 2013
Severe intestinal toxicity after stereotactic ablative radiotherapy for abdominopelvic malignanciesSun Hyun Bae, Mi-Sook Kim, So Young Kim, et al.
Experimental & Molecular Medicine|October 16, 2007
Mutation analysis of p31comet gene, a negative regulator of Mad2, in human hepatocellular carcinomaMi-Yong Yun, Sang Bum Kim, Sunhoo Park, et al.
Clinical and Molecular Hepatology|April 3, 2015
Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cellsHa Ra Gu, Su Cheol Park, Su Jin Choi, et al.
Cancers|December 11, 2022
NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP SignalingYuna Shin, Wonhee Jung, Mi-Yeon Kim, et al.
The Korean Journal of Hepatology|December 23, 2004
[Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma]Yun Ho Kong, Chul Ju Han, Sang Dae Lee, et al.
Anticancer Research|August 9, 2015
Survival Advantage Associated with Metformin Usage in Hepatocellular Carcinoma Patients Receiving Radiotherapy: A Propensity Score Matching AnalysisWon Il Jang, Mi-Sook Kim, Jung Sub Lim, et al.
Journal of Cellular Biochemistry|June 18, 2005
Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen speciesMyung-Jin Park, Jae-Young Lee, Hee-Jin Kwak, et al.
Journal of Medical Virology|April 23, 2008
High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in KoreaSu Cheol Park, Sook-Hyang Jeong, Jin Kim, et al.
Cancer|May 10, 2012
Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolizationJin-Kyu Kang, Mi-Sook Kim, Chul Koo Cho, et al.
Oncology Reports|July 18, 2018
TMEM165, a Golgi transmembrane protein, is a novel marker for hepatocellular carcinoma and its depletion impairs invasion activityJee-San Lee, Mi-Yeun Kim, Eun-Ran Park, et al.
Pageof 5